Nuvectis Pharma Competitors and Similar CompaniesClear all
Nuvectis Pharma's competitors and similar companies include Immunicom, MaveriX Oncology, SEEKYO and MaxCyte.
 Nuvectis Pharma Nuvectis Pharma (formerly known as Centry Pharma) is a biopharmaceutical company focused on precision medicines for cancer treatment. |  Immunicom Immunicom is a company that develops and commercializes a non-drug-based cancer therapy in order to reduce treatment side effects and enhance its response rates. |  MaveriX Oncology MaveriX Oncology is a biotechnology company focused on the discovery, development, and commercialization of targeted small-molecule cancer chemo-immunotherapies. |  MaxCyte MaxCyte (formerly known as Theramed) is a cell engineering company focused on providing platform technologies for cell-based research as well as cell therapeutic discovery, development, and commercialization. | ||
Founding Date | Founding Date 2020 | Founding Date 2013 | Founding Date 2014 | Founding Date 2018 | Founding Date 1998 |
Type | Type Public | Type Private | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Fort Lee, US HQ | Locations San Diego, US HQ | Locations Palo Alto, US HQ | Locations Poitiers, FR HQ Chasseneuil Du Poitou, FR | Locations Gaithersburg, US HQ Alderley Edge, GB |
Employees | Employees 6 | Employees 22 | Employees 3 | Employees 833% increase | Employees 65 |
Valuation ($) | Valuation ($) 146.8 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 387.9 m |
Financial | |||||
Cost of goods | Cost of goods $2.1m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $6.2m (FY, 2025) |
Net income | Net income ($26.4m) (FY, 2025) | Net income N/A | Net income N/A | Net income N/A | Net income ($44.6m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 1.9m (over 6 years ago) | Latest funding round $ 6.5m (over 6 years ago) | Latest funding round $ 720.5k (over 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 15.3m | Total funding raised $ 21.9m | Total funding raised $ 6.5m | Total funding raised $ 720.5k | Total funding raised $ 31.3m |
For sources of this data, please see the company profile
View Company Profiles
Immunicom
HQ
San Diego, US
Employees
22
Immunicom is a company that develops and commercializes a non-drug-based cancer therapy in order to reduce treatment side effects and enhance its response rates.
View companyMaveriX Oncology
HQ
Palo Alto, US
Employees
3
MaveriX Oncology is a biotechnology company focused on the discovery, development, and commercialization of targeted small-molecule cancer chemo-immunotherapies.
View company
SEEKYO
HQ
Poitiers, FR
Employees
8↑ 33% increase
SEEKYO is a biotech company that provides chemotherapies without adverse effects.
View companyMaxCyte
HQ
Gaithersburg, US
Employees
65
MaxCyte (formerly known as Theramed) is a cell engineering company focused on providing platform technologies for cell-based research as well as cell therapeutic discovery, development, and commercialization.
View company